NCT02780284 Microbiome, Exercise Tracking Study: Among Individuals at High Risk for Colorectal Cancer Status COMPLETED Phase NA
NCT02777710 Evaluation of Safety and Activity of an Anti-PDL1 Antibody (DURVALUMAB) Combined With CSF-1R TKI (PEXIDARTINIB) in Patients With Metastatic/Advanced Pancreatic or Colorectal Cancers Status COMPLETED Phase PHASE1
NCT02758951 Perioperative Systemic Therapy for Isolated Resectable Colorectal Peritoneal Metastases Status ACTIVE_NOT_RECRUITING Phase PHASE2/PHASE3
NCT02754115 An Audit of Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy Status RECRUITING Phase N/A
NCT02753127 A Study of Napabucasin (BBI-608) in Combination With FOLFIRI in Adult Patients With Previously Treated Metastatic Colorectal Cancer Status COMPLETED Phase PHASE3
NCT02751892 The Feasibility of an Active Lifestyle Programme in Patients Recovering From Colorectal Cancer Status COMPLETED Phase NA
NCT02746224 Reconstruction Techniques and Vascular Approach After Laparoscopic Left Hemicolectomy and Rectum Low Anterior Resection Status COMPLETED Phase NA
NCT02745769 A Study in Advanced Cancers Using Ramucirumab (LY3009806) and Other Targeted Agents Status COMPLETED Phase PHASE1
NCT02744274 Efficacy of Acupuncture in Prevention of Chemotherapy Induced Peripheral Neuropathy - a Pilot Study Status UNKNOWN Phase PHASE3
NCT02732860 Personalized Patient Derived Xenograft (pPDX) Modeling to Test Drug Response in Matching Host Status RECRUITING Phase N/A
NCT02726334 A Phase I, Dose Escalation Study of BNC101 in Patients With Metastatic Colorectal Cancer. Status TERMINATED Phase PHASE1
NCT02726243 Intestinal Microbiota and Colorectal Cancer in Inflammatory Bowel Disease Status COMPLETED Phase N/A
NCT02720926 Study of TKI 258 in Combination With Xeloda and Oxaliplatin in Advanced Colorectal and Gastric Cancer Status TERMINATED Phase PHASE1
NCT02718430 VXM01 Phase I Study in Patients With Metastatic Colorectal Cancer With Liver Metastasis Status COMPLETED Phase PHASE1
NCT02715882 Clinical Study of Safety and Tolerability of CBLB502 as a Neo-adjuvant Treatment in Patients With Colorectal Cancer Status UNKNOWN Phase PHASE2
NCT02713984 A Clinical Research of CAR T Cells Targeting HER2 Positive Cancer Status WITHDRAWN Phase PHASE1/PHASE2
NCT02713529 Safety and Efficacy Study of AMG 820 and Pembrolizumab Combination in Select Advanced Solid Tumor Cancer Status COMPLETED Phase PHASE1/PHASE2